Glenmark Pharma gets USFDA nod for generic skin inflammation treatment foam

The company said its current portfolio consists of 150 products authorised for distribution in the US and 52 ANDA's pending approval with the USFDA

from Latest News http://bit.ly/2Ihcz9p
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share